| abstract |
Use of at least one salt in the manufacture of or in cosmetic, pharmaceutical or dermatological compositions for: (i) treating pain associated with at least one cutaneous disorder selected from shingles, post-zoster, burns, seborrheic eczema, demodiciosis, cutaneous ulcers and fibrosis; (ii) controlling hypertrophic cicatrisation; and/or (iii) treating acne rosacea. (I) is selected from salts of yttrium, lanthanum, cerium, praseodymium, neodymium, promethium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, tin, zinc, manganese, cobalt, barium and strontium. |